eXoZymes Stock (NASDAQ:EXOZ)

Ownership Financials Chart

Previous Close

$4.70

52W Range

$4.66 - $18.40

50D Avg

$7.98

200D Avg

$10.42

Market Cap

$43.72M

Avg Vol (3M)

$8.58K

Beta

2.74

Div Yield

EXOZ Company Profile

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Nov 13, 2024

Website

EXOZ Performance

EXOZ Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-5.93M	$-1.80M	$-1.33M
Net Income	$-5.86M	$-2.04M	$-1.40M
EBITDA	$-5.66M	$-1.60M	$-1.18M
Basic EPS	-	$-0.25	$-0.17
Diluted EPS	-	$-0.25	$-0.17

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

Ticker	Company
SRZN	Surrozen, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
GLSI	Greenwich LifeSciences, Inc.
TVGN	Tevogen Bio Holdings Inc.
CGTX	Cognition Therapeutics, Inc.
TLSA	Tiziana Life Sciences Ltd
ONCY	Oncolytics Biotech Inc.
TIL	Instil Bio, Inc.
ATOS	Atossa Therapeutics, Inc.
ESLA	Estrella Immunopharma, Inc.